MAXPHARMA
Board
1 director, 1 in day-to-day management, last change in 2025Managing director, permanent representative
managing director since 01-01-2025
managing director appointed by deed of 24-01-2025
listed in the 2025 annual accounts, filed on 01-07-2026
Permanent representatives 1
Mandates through the years
5 names, the dashed line is todayManaging director
Managing director
Managing director
Managing director
Managing director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Managing director, since before 31-12-2024
- Managing director, appointed by deed of 24-01-2025, still in office
-
- Managing director, from 02-05-2018 to 24-01-2025
- Managing director, appointed by deed of 18-03-2022, until 24-01-2025
-
- Director, from before 02-05-2018 to 18-03-2022
- Managing director, from before 02-05-2018 to 18-03-2022
-
- Managing director, from 02-05-2018 to 30-07-2021
-
- Director, from before 02-05-2018, last mentioned in 2018
- Managing director, from before 02-05-2018, last mentioned in 2018
Control
Parent
Equity €141,142
Profit €42,183 in 2025
Checked score
Source: accounts 2025
100%
This company
MAXPHARMA
Equity €284,725
Profit €15,264 in 2025
Capital
- Capital
- €61,973.38
- Shares
- 250 in the deed of 05-02-2018
- Source
- deed of 05-02-2018
Owners through the years
as the annual accounts name themOwners as a list
-
- 2024: consolidates
- 2025: 100%
Source: parent in its own accounts, lists of holdings in the owners' accounts
Capital transactions
Capital over time
- 05-02-2018 Capital reduction of €99,000 · to €61,973.38 · repaid to the shareholders
- 05-02-2018 Incorporation · BEF 2,500,000 · 250 shares
- 05-02-2018 Capital increase of €99,000 · to €160,973.38 · 396 new shares · in cash